Search results
Less than half of nursing home residents are up to date with their COVID-19 vaccines, study finds:...
Yahoo Life· 5 days agoHere’s your go-to guide with everything you need to know about COVID-19, including testing expanding...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 2 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
COVID Vaccine Study Finds Small Signal of Seizure Risk in Young Kids
MedPage Today· 3 days agoData gathered from over 4 million children revealed that myocarditis or pericarditis occurred at...
These Biotech Stocks Could Soar 120% and 295%, According to Wall Street
Motley Fool via Yahoo Finance· 6 days agoAnd that spurred the stock's progressive decline. The shares now are down about 98% from their high...
The path to a better tuberculosis vaccine runs through Montana
KPAX Missoula· 6 days agoA team of Montana researchers is playing a key role in the development of a more effective vaccine against tuberculosis, an infectious disease that has killed more people ...
UK virtually ends free vaccines as COVID-19 continues to spread
World Socialist Web Site· 5 days agoMore than four years since the UK reported its initial case of COVID-19, the virus continues to...
3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition
InvestorPlace· 2 days agoIf you have a high tolerance for volatility then the biotech sector might be for you. Biotech stocks...
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 2 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
Europe Strengthens Future Disease Defense
Medscape· 23 hours agoA network of health security agencies has been established in Europe and Central Asia to bolster the region's preparedness to meet future disease...
How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 4 days agoInvestor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine,...